Buy Methoxphenidine Powder

Buy Methoxphenidine Powder (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a diarylethylamine class dissociative that has been offered for sale as a designer drug on the internet. The first mention of methylphenidine appeared in a 1989 patent, when it was investigated as a possible remedy for neurotoxic damage.

Methoxphenidine and the related substance diphenidine were available on the gray market shortly after the UK banned arylcyclohexylamines in 2013. It can be found there in tablet and powder form. Anecdotal accounts indicate that methoxphenidine has better oral potency than diphenidine, despite diphenidine having a stronger affinity for the NMDA receptor. The arylcyclohexylamines exhibit a structure-activity relationship whereby methoxphenidine has a higher affinity for the NMDA receptor than 4-MeO-Diphenidine but a lower affinity than 3-MeO-diphenidine among the three isomeric anisyl-substituents.

Side effects
It has been documented that acute methoxphenidine intoxication can result in tachycardia, hypertension, and confusion that can be resolved with intravenous lorazepam therapy. Methoxphenidine has also been linked to one case of driving while intoxicated and three documented fatalities.

Psychotic episodes have also been reported, including a murder in June 2014.

Legal status
As of October 2015 MXP is a controlled substance in China.

MXP is also banned in Sweden.

In Canada, MT-45 and its analogues were made Schedule I controlled substances. Possession without legal authority can result in maximum of 7 years of imprisonment. Further, Health Canada amended the Food and Drug Regulations in May, 2016 to classify MXP as a restricted drug. Only those with a law enforcement agency, a person with an exemption permit, or institutions with the minister’s authorization may possess the drug.

Chemical and physical data
Formula: C20H25NO

Molar mass: 295.4186 g/mol g·mol?1

See also
AD-1211
Diphenidine
Ephenidine
Fluorolintane
Lanicemine
Lefetamine
NMDA receptor antagonist
Phencyclidine

r